(Q46403531)

English

Characterization of total plasma glycosaminoglycan levels in healthy volunteers following oral administration of a novel antithrombotic odiparcil with aspirin or enoxaparin

scientific article published on 29 August 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18757783

Characterization of total plasma glycosaminoglycan levels in healthy volunteers following oral administration of a novel antithrombotic odiparcil with aspirin or enoxaparin (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18757783

1 reference

based on heuristic

inferred from title

author name string

Alan L Myers

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18757783

Vijay V Upreti

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18757783

Manoj Khurana

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18757783

Natalie D Eddington

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18757783

publication date

29 August 2008

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18757783

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18757783

48

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18757783

10

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18757783

1158-1170

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18757783

Venous thromboembolism: pathophysiology, clinical features, and prevention

1 reference

https://api.crossref.org/works/10.1177%2F0091270008323751

21 January 2018

The oral anticoagulant saga: past, present, and future

1 reference

https://api.crossref.org/works/10.1177%2F0091270008323751

21 January 2018

Pharmacogenetics, drug-metabolizing enzymes, and clinical practice

1 reference

https://api.crossref.org/works/10.1177%2F0091270008323751

21 January 2018

Cerebral haemorrhage induced by warfarin - the influence of drug-drug interactions.

1 reference

https://api.crossref.org/works/10.1177%2F0091270008323751

21 January 2018

Pharmacogenetics of target genes across the warfarin pharmacological pathway

1 reference

https://api.crossref.org/works/10.1177%2F0091270008323751

21 January 2018

Quality improvement case study: warfarin sodium interactions

1 reference

https://api.crossref.org/works/10.1177%2F0091270008323751

21 January 2018

Spontaneously reported fatal suspected adverse drug reactions: a 10-year survey from Sweden

1 reference

https://api.crossref.org/works/10.1177%2F0091270008323751

21 January 2018

Oral anticoagulants in development: focus on thromboprophylaxis in patients undergoing orthopaedic surgery

1 reference

https://api.crossref.org/works/10.1177%2F0091270008323751

21 January 2018

New anticoagulants for treatment of venous thromboembolism

1 reference

https://api.crossref.org/works/10.1177%2F0091270008323751

21 January 2018

Beyond heparin and warfarin: the new generation of anticoagulants

1 reference

https://api.crossref.org/works/10.1177%2F0091270008323751

21 January 2018

Discovery of the novel antithrombotic agent 5-chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): an oral, direct factor Xa inhibitor

1 reference

https://api.crossref.org/works/10.1177%2F0091270008323751

21 January 2018

Idraparinux versus standard therapy for venous thromboembolic disease

1 reference

https://api.crossref.org/works/10.1177%2F0091270008323751

21 January 2018

Determination of endogenous glycosaminoglycans derived disaccharides in human plasma by HPLC: validation and application in a clinical study

1 reference

https://api.crossref.org/works/10.1177%2F0091270008323751

21 January 2018

Pretreatment procedure for the microdetermination of chondroitin sulfate in plasma and urine

1 reference

https://api.crossref.org/works/10.1177%2F0091270008323751

21 January 2018

Molecular weight-dependent distribution of acidic glycosaminoglycans in human plasma

1 reference

https://api.crossref.org/works/10.1177%2F0091270008323751

21 January 2018

Chondroitin sulfate anticoagulant activity is linked to water transfer: relevance to proteoglycan structure in atherosclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F0091270008323751

21 January 2018

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1177%2F0091270008323751

21 January 2018

Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

1 reference

https://api.crossref.org/works/10.1177%2F0091270008323751

21 January 2018

Recent advances in the study of the biosynthesis and functions of sulfated glycosaminoglycans

1 reference

https://api.crossref.org/works/10.1177%2F0091270008323751

21 January 2018

Modification of plasma glycosaminoglycans in long distance runners

1 reference

https://api.crossref.org/works/10.1177%2F0091270008323751

21 January 2018

Determination of the chondroitin sulfate disaccharides in dog and horse plasma by HPLC using chondroitinase digestion, precolumn derivatization, and fluorescence detection

1 reference

https://api.crossref.org/works/10.1177%2F0091270008323751

21 January 2018

Aspirin as an antiplatelet drug

1 reference

https://api.crossref.org/works/10.1177%2F0091270008323751

21 January 2018

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety

1 reference

https://api.crossref.org/works/10.1177%2F0091270008323751

21 January 2018

Do preclinical testing strategies help predict human hepatotoxic potentials?

1 reference

https://api.crossref.org/works/10.1177%2F0091270008323751

21 January 2018

Elevation of hepatic transaminases after enoxaparin use: case report and review of unfractionated and low-molecular-weight heparin-induced hepatotoxicity

1 reference

https://api.crossref.org/works/10.1177%2F0091270008323751

21 January 2018

Low molecular weight heparin-induced liver toxicity

1 reference

https://api.crossref.org/works/10.1177%2F0091270008323751

21 January 2018

Conformational flexibility: a new concept for explaining binding and biological properties of iduronic acid-containing glycosaminoglycans

1 reference

https://api.crossref.org/works/10.1177%2F0091270008323751

21 January 2018

Structure and properties of dermatan sulphate proteoglycans

1 reference

https://api.crossref.org/works/10.1177%2F0091270008323751

21 January 2018

Identifiers

10.1177/0091270008323751

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18757783

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18757783

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46403531&oldid=2109690235"